Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.08 is 50% above its 2-year average of 3.38, around the middle of its 2-year range (0.00–8.60).
As of the fiscal period ended Tuesday, June 30, 2026. 9.41% below its 12-month average of 5.61.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.08.
CURRENT RATIO
5.08
CURRENT RATIO AVG TTM
5.61
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.41%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.40
median of 616 covered companies
CURRENT VS SECTOR MEDIAN
+49.63%
vs the sector median at left
Heartflow, Inc. Common Stock
Market Cap
$4.35B
Current Ratio
5.08
TTM Avg
5.61
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.38B
Current Ratio
0.84
TTM Avg
0.80
3Y Avg
0.95
5Y Avg
1.27
Market Cap
$4.41B
Current Ratio
4.79
TTM Avg
3.12
3Y Avg
4.00
5Y Avg
4.41
Market Cap
$4.24B
Current Ratio
16.24
TTM Avg
19.89
3Y Avg
20.20
5Y Avg
22.94
Market Cap
$4.59B
Current Ratio
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$4.64B
Current Ratio
1.38
TTM Avg
1.51
3Y Avg
1.37
5Y Avg
1.46
Market Cap
$4.00B
Current Ratio
12.77
TTM Avg
10.57
3Y Avg
9.28
5Y Avg
8.78
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heartflow, Inc. Common Stock (HTFL) | $4.35B | 5.08 | 5.61 | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.38B | 0.84 | 0.80 | 0.95 | 1.27 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.41B | 4.79 | 3.12 | 4.00 | 4.41 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.24B | 16.24 | 19.89 | 20.20 | 22.94 |
| LivaNova PLC (LIVN)vs › | $4.14B | 1.45 | 2.12 | 2.54 | 2.24 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.59B | 6.95 | 6.77 | 6.23 | 10.87 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.64B | 1.38 | 1.51 | 1.37 | 1.46 |
| AbCellera Biologics Inc. (ABCL)vs › | $4.00B | 12.77 | 10.57 | 9.28 | 8.78 |
| BillionToOne, Inc. (BLLN)vs › | $4.71B | 11.69 | 9.86 | 7.15 | 7.15 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.72B | 26.10 | 14.27 | 14.23 | 14.47 |
Current Ratio
5.08
Quick Ratio
5.08
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.08 |
| 2026-03-31 | 5.57 |
| 2025-12-31 | 5.20 |
| 2025-09-30 | 8.60 |
| 2025-06-30 | 3.60 |
| 2025-03-31 | 3.33 |
| 2024-12-31 | 2.45 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 0.00 |
